Two Sigma Advisers
MDGL icon

Two Sigma Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Two Sigma Advisers’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-900
Closed -$261K – 2681
2022
Q4 		$261K Buy
+900
New +$88K ﹤0.01% 2112
2022
Q2 		– Sell
-2,982
Closed -$293K – 2797
2022
Q1 		$293K Sell
2,982
-2,200
-42% -$185K ﹤0.01% 2227
2021
Q4 		$439K Sell
5,182
-30,458
-85% -$2.5M ﹤0.01% 1973
2021
Q3 		$2.84M Sell
35,640
-49,300
-58% -$4.26M 0.01% 1064
2021
Q2 		$8.27M Sell
84,940
-30,900
-27% -$3.66M 0.02% 644
2021
Q1 		$13.6M Buy
115,840
+76,300
+193% +$8.9M 0.04% 466
2020
Q4 		$4.4M Buy
39,540
+21,000
+113% +$2.57M 0.01% 877
2020
Q3 		$2.2M Buy
18,540
+6,342
+52% +$689K 0.01% 1113
2020
Q2 		$1.38M Buy
+12,198
New +$1.2M ﹤0.01% 1413
2019
Q1 		– Sell
-19,698
Closed -$2.22M – 2387
2018
Q4 		$2.22M Buy
19,698
+11,789
+149% +$1.82M 0.01% 1130
2018
Q3 		$1.69M Buy
7,909
+700
+10% +$176K ﹤0.01% 1308
2018
Q2 		$2.02M Buy
7,209
+400
+6% +$70.2K 0.01% 1287
2018
Q1 		$795K Buy
+6,809
New +$841K ﹤0.01% 1643
2016
Q2 		– Sell
-785
Closed -$7K – 2136
2016
Q1 		$7K Sell
785
-5,981
-88% -$50K ﹤0.01% 2014
2015
Q4 		$83K Buy
+6,766
New +$186K ﹤0.01% 1787

Other funds holding MDGL

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Two Sigma Advisers's MDGL Position: Q1 2023 in Review

Two Sigma Advisers sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2023, closing a stake of 900 shares — an estimated $261K sold.

Two Sigma Advisers first reported a position in MDGL in Q4 2015 and held it in 15 quarters. The position peaked at $13.6M in Q1 2021. 223 funds tracked by Wall St. Rank hold MDGL as of Q1 2023.

  • Two Sigma Advisers reported no remaining Madrigal Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 900 Madrigal Pharmaceuticals shares in Q1 2023, an estimated $261K.
  • Two Sigma Advisers first reported a position in Madrigal Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Two Sigma Advisers's Madrigal Pharmaceuticals position peaked at $13.6M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.